MT-TL1
MT-TL1 is a gene that in humans is responsible for encoding the mitochondrial tRNA for leucine. This gene is located within the mitochondrial DNA, specifically in the mitochondrial genome. Mutations in this gene have been associated with various diseases, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), and Leber's hereditary optic neuropathy (LHON).
Structure[edit]
The MT-TL1 gene is located on the mitochondrial genome at position 3230-3304. It is a small gene, consisting of only 75 base pairs. The structure of the MT-TL1 gene is unique in that it lacks introns, a characteristic feature of mitochondrial genes.
Function[edit]
The MT-TL1 gene encodes the mitochondrial tRNA for leucine. tRNA is a type of RNA molecule that helps decode a messenger RNA (mRNA) sequence into a protein. In this case, the MT-TL1 gene helps in the synthesis of proteins that are essential for the normal functioning of the mitochondria.
Clinical significance[edit]
Mutations in the MT-TL1 gene have been associated with several mitochondrial diseases. These include:
- Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS): This is a condition that affects many of the body's systems, particularly the brain and nervous system (encephalo-) and muscles (myopathy).
- Myoclonic epilepsy with ragged-red fibers (MERRF): This is a disorder that affects many parts of the body, particularly the muscles and nervous system.
- Leber's hereditary optic neuropathy (LHON): This is an inherited form of vision loss that predominantly affects males.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
